Roderick Skinner

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. ncbi request reprint Long-term follow-up of people who have survived cancer during childhood
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
    Lancet Oncol 7:489-98. 2006
  2. doi request reprint Developing international consensus for late effects screening and guidance
    Rod Skinner
    Great North Children s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Curr Opin Support Palliat Care 7:303-8. 2013
  3. ncbi request reprint Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7
    R Skinner
    Department of Paediatric and Adolescent Oncology, and Children s BMT Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
    Pediatr Blood Cancer 50:670-2. 2008
  4. ncbi request reprint Preventing platinum-induced ototoxicity in children-is there a potential role for sodium thiosulfate?
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    Pediatr Blood Cancer 47:120-2. 2006
  5. ncbi request reprint Prevention and management of central venous catheter occlusion and thrombosis in children with cancer
    Roderick Skinner
    Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Pediatr Blood Cancer 50:826-30. 2008
  6. ncbi request reprint Chronic ifosfamide nephrotoxicity in children
    R Skinner
    Sir James Spence Institute of Child Health, University of Newcastle upon Tyne, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, United Kingdom
    Med Pediatr Oncol 41:190-7. 2003
  7. ncbi request reprint Prevention of varicella in children with cancer: Is it time to reconsider our strategy?
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, United Kingdom
    Pediatr Blood Cancer 51:451-2. 2008
  8. doi request reprint Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK
    Eur J Cancer 45:3213-9. 2009
  9. doi request reprint Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    Pediatr Blood Cancer 54:983-9. 2010
  10. doi request reprint Nephrotoxicity--what do we know and what don't we know?
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    J Pediatr Hematol Oncol 33:128-34. 2011

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Long-term follow-up of people who have survived cancer during childhood
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
    Lancet Oncol 7:489-98. 2006
    ..This review discusses the present provision of long-term follow-up, and summarises information that might facilitate design and implementation of future models of long-term follow-up care...
  2. doi request reprint Developing international consensus for late effects screening and guidance
    Rod Skinner
    Great North Children s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Curr Opin Support Palliat Care 7:303-8. 2013
    ..This diversity has generated uncertainty about the ideal nature and content of LTFU...
  3. ncbi request reprint Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7
    R Skinner
    Department of Paediatric and Adolescent Oncology, and Children s BMT Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
    Pediatr Blood Cancer 50:670-2. 2008
    ..This case suggests that DLI and graft-versus-myelodysplasia (GVMDS) may be beneficial in post-transplant relapse of pediatric myelodysplasia...
  4. ncbi request reprint Preventing platinum-induced ototoxicity in children-is there a potential role for sodium thiosulfate?
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    Pediatr Blood Cancer 47:120-2. 2006
  5. ncbi request reprint Prevention and management of central venous catheter occlusion and thrombosis in children with cancer
    Roderick Skinner
    Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Pediatr Blood Cancer 50:826-30. 2008
    ..The views and clinical practice of children's cancer units were surveyed regarding management of central venous catheter (CVC) occlusion (CVC-occlusion), CVC-related thrombosis (CVC-thrombosis) and thromboembolism (CVC-thromboembolism)...
  6. ncbi request reprint Chronic ifosfamide nephrotoxicity in children
    R Skinner
    Sir James Spence Institute of Child Health, University of Newcastle upon Tyne, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, United Kingdom
    Med Pediatr Oncol 41:190-7. 2003
    ..The pathogenesis of ifosfamide nephrotoxicity is poorly understood. There is an urgent need for the development and clinical investigation of nephroprotective strategies...
  7. ncbi request reprint Prevention of varicella in children with cancer: Is it time to reconsider our strategy?
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, United Kingdom
    Pediatr Blood Cancer 51:451-2. 2008
  8. doi request reprint Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK
    Eur J Cancer 45:3213-9. 2009
    ..The long-term outcome of platinum-induced nephrotoxicity is unknown. This prospective single-centre longitudinal cohort study evaluated long-term changes following treatment in childhood...
  9. doi request reprint Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    Pediatr Blood Cancer 54:983-9. 2010
    ..This prospective longitudinal single institution cohort study evaluated the natural history of and risk factors for chronic nephrotoxicity 10 years after ifosfamide treatment in childhood...
  10. doi request reprint Nephrotoxicity--what do we know and what don't we know?
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    J Pediatr Hematol Oncol 33:128-34. 2011
    ....
  11. pmc Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how?
    Roderick Skinner
    Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
    Arch Dis Child 92:257-60. 2007
    ..It is of paramount importance to ascertain and meet the needs of survivors themselves...
  12. pmc Nephrotoxicity in survivors of Wilms' tumours in the North of England
    S Bailey
    Department of Child Health, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UK
    Br J Cancer 87:1092-8. 2002
    ..This finding will enable paediatric oncologists to reassure patients and parents that treatment for Wilms' tumour rarely causes long-term renal impairment...
  13. doi request reprint Renal and pulmonary late effects of cancer therapy
    Roderick Skinner
    Department of Paediatric and Adolescent Haematology Oncology, Great North Children s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    Semin Oncol 40:757-73. 2013
    ....
  14. pmc The influence of ifosfamide scheduling on acute nephrotoxicity in children
    M W English
    Sir James Spence Institute of Child Health, The Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Br J Cancer 75:1356-9. 1997
    ..Subclinical acute nephrotoxicity was demonstrated with both schedules, but there were no significant differences in severity...
  15. doi request reprint Views of childhood cancer survivors and their families on the provision and format of a treatment summary
    Emma Rebecca Firth
    School of Medicine, Sheffield University, Newcastle upon Tyne, UK
    J Pediatr Hematol Oncol 35:193-6. 2013
    ..There is relatively little research into opinions of service users on the provision and format of treatment summaries...
  16. pmc Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group
    R Skinner
    Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Br J Cancer 82:1636-45. 2000
    ..Restriction of total ifosfamide dose to < 84 g/m2 will reduce the frequency of, but not abolish, clinically significant nephrotoxicity, whilst doses > 119 g/m2 are associated with a very high risk of severe toxicity...
  17. pmc Should paediatric central lines be aspirated before use?
    Malcolm G Coulthard
    Department of Pediatric Nephrology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Arch Dis Child 92:517-8. 2007
    ..Daily use, as with long-term parenteral nutrition, might result in >3 g of clot being embolised annually. Consideration should be given to aspirating all paediatric central lines before use...
  18. doi request reprint Invasive aspergillosis of the small bowel in an infant with acute myeloid leukemia and intestinal obstruction
    James T Hayden
    Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
    Pediatr Hematol Oncol 26:84-91. 2009
    ..Invasive aspergillosis may unusually present at nonpulmonary sites at initial presentation of acute leukemia. Microbiological or histological diagnosis is needed to guide aggressive appropriate management...
  19. pmc Cisplatin dose rate as a risk factor for nephrotoxicity in children
    R Skinner
    Sir James Spence Institute of Child Health, University of Newcastle upon Tyne, Royal Victoria Infirmary, UK
    Br J Cancer 77:1677-82. 1998
    ..Despite partial recovery of GFR, the long-term outcome of nephrotoxicity remains unknown and careful monitoring of chronic toxicity is necessary...
  20. pmc Dose-related nephrotoxicity of carboplatin in children
    M W English
    Sir James Spence Institute of Child Health, The Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Br J Cancer 81:336-41. 1999
    ..GFR and SMg should be carefully monitored when high CDs of carboplatin are used, or if carboplatin is combined with other nephrotoxic chemotherapy...
  21. ncbi request reprint Plasma coenzyme Q(10) in children and adolescents undergoing doxorubicin therapy
    S Eaton
    Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Queen Victoria Road, NE1 4LP, Newcastle upon Tyne, UK
    Clin Chim Acta 302:1-9. 2000
    ..We conclude that the cardiotoxicity due to doxorubicin therapy does not involve acute myocardial depletion of coenzyme Q(10)...
  22. ncbi request reprint Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment
    R P S Bajwa
    Childrens Bone Marrow Transplant Unit, Newcastle General Hospital, Newcastle upon Tyne, UK
    Bone Marrow Transplant 31:591-7. 2003
    ..Our experience suggests rtPA and heparin are an effective treatment for HVOD in children, with relatively little toxicity provided therapy is started before MOF develops...
  23. ncbi request reprint Best practice in assessing ototoxicity in children with cancer
    Roderick Skinner
    Eur J Cancer 40:2352-4. 2004
  24. pmc Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres
    Bob Phillips
    Paediatric Oncology Day Hospital, St James s Hospital, Leeds, UK
    Arch Dis Child 92:495-8. 2007
    ..To assess the variation in the current UK management strategies for the treatment of febrile neutropenia in childhood. Design and..